Email :
Contact : (321) 445-1969

Immunotherapeutic Approach to Laryngeal Cancer


Laryngeal cancer is a rare cancer, accounts for 12,630 new cases in 2014 out of a total number of 1,665,540 new cancer cases in the United States. It is mostly Squamous in origin as the rest of head and neck tumors. Immunotherapy is an alternative to chemotherapy and radiation therapy to treat cancer. It is utilized to stimulate ones own immune system to fight the tumor. Giving someone synthetic immune system proteins to fight cancer can also be done in immunotherapy. In this paper, we discuss the pathophysiology of Laryngeal Cancer itself and as part of the squamous cell cancer of head and neck, the active molecules involved in immunotherapy, as well as potential ways to fight these cancers using immunotherapy.

Download Pdf